Clinical Trials List
Protocol NumberSPC-RO-201903
2019-09-01 - 2021-09-30
Phase IV
Recruiting1
-
Trial Applicant
SHINER PHARM CORP.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 劉妙真 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
55 participants
-
Global
0 participants
